Research Peptides Hcg

Human chorionic gonadotropin (HCG) is a glycoprotein hormone widely investigated in preclinical research for its structural and functional homology to luteinizing hormone (LH). Laboratory scientists utilize high-purity research peptides HCG to evaluate LH receptor signaling cascades, steroidogenesis pathways, and cellular differentiation models. PX1 Research supplies high-grade research compounds strictly for in vitro and laboratory experimental protocols.

GMP-compliant U.S. facilities
ISO 17025 third-party COAs
100% domestic — no imports
Fast tracked domestic shipping
Shop research peptides

Quick answer

Human chorionic gonadotropin (HCG) is a glycoprotein hormone widely investigated in preclinical research for its structural and functional homology to luteinizing hormone (LH). Laboratory scientists utilize high-purity research peptides HCG to evaluate LH receptor signaling cascades, steroidogenesis pathways, and cellular differentiation models. PX1 Research supplies high-grade research compounds strictly for in vitro and laboratory experimental protocols.

Reviewed by PX1 Research scientific team

Key takeaways

  • In biomedical research, research peptides HCG refer to highly purified human chorionic gonadotropin formulations utilized to investigate luteinizing hormone/choriogonadotropin receptor (LHCGR) activation, downstream steroidogenesis, and reproductive cell signaling.
  • Human chorionic gonadotropin is a heterodimeric glycoprotein composed of an alpha (α) subunit containing 92 amino acids and a beta (β) subunit containing 145 amino acids.
  • Upon binding to the G-protein coupled luteinizing hormone/choriogonadotropin receptor (LHCGR), research peptides HCG initiate conformational shifts that stimulate heterotrimeric Gs proteins.
  • When designing preclinical protocols to evaluate the hypothalamic-pituitary-gonadal (HPG) axis, researchers often contrast direct receptor agonists with upstream regulatory peptides.

Primary Definition and Laboratory Role of Research Peptides HCG

In biomedical research, research peptides HCG refer to highly purified human chorionic gonadotropin formulations utilized to investigate luteinizing hormone/choriogonadotropin receptor (LHCGR) activation, downstream steroidogenesis, and reproductive cell signaling. Supplied strictly as a research compound for in vitro and laboratory experimental models, HCG allows investigators to evaluate gonadotropin receptor binding kinetics without endogenous pituitary axis feedback interference.

Because of its shared alpha-subunit identity with LH, FSH, and TSH, alongside a unique beta-subunit that conveys prolonged receptor engagement, HCG serves as an essential reference standard in cell culture, tissue explant, and animal model research. Facilities sourcing from PX1 Research receive reference-grade material validated via rigorous analytical testing.

Molecular Structure and Structural Homology of HCG

Human chorionic gonadotropin is a heterodimeric glycoprotein composed of an alpha (α) subunit containing 92 amino acids and a beta (β) subunit containing 145 amino acids. Preclinical structural analyses demonstrate that the α-subunit is structurally identical to those found in luteinizing hormone (LH), follicle-stimulating hormone (FSH), and thyroid-stimulating hormone (TSH). The biological specificity of HCG is dictated by its distinct β-subunit, which contains a carboxyl-terminal peptide (CTP) with four O-linked oligosaccharide chains.

This post-translational glycosylation significantly extends the biological half-life of HCG in comparative models relative to native LH. In laboratory assays evaluating gonadotropin signaling, the extended half-life allows researchers to examine sustained receptor activation and intracellular cascade longevity without requiring continuous micro-infusion techniques.

LHCGR Binding Pathways and Intracellular Cascades

Upon binding to the G-protein coupled luteinizing hormone/choriogonadotropin receptor (LHCGR), research peptides HCG initiate conformational shifts that stimulate heterotrimeric Gs proteins. In vitro studies show that this interaction triggers adenylyl cyclase activity, increasing intracellular cyclic adenosine monophosphate (cAMP) accumulation and activating protein kinase A (PKA) cascades.

Downstream signaling leads to the phosphorylation of transcription factors such as CREB, upregulation of the steroidogenic acute regulatory (StAR) protein, and elevated expression of cytochrome P450 enzymes (CYP11A1, CYP17A1). Preclinical rodent models indicate that this pathway regulates the rate-limiting conversion of cholesterol to pregnenolone, providing an established mechanism for investigating testicular and ovarian steroidogenic capacity in controlled laboratory environments.

Comparative Analysis: HCG vs. Related Gonadotropic Research Compounds

When designing preclinical protocols to evaluate the hypothalamic-pituitary-gonadal (HPG) axis, researchers often contrast direct receptor agonists with upstream regulatory peptides. While research peptides HCG act directly on peripheral LHCGR sites to induce steroidogenesis, compounds like Gonadorelin function at the pituitary level by binding to GnRH receptors to stimulate endogenous LH and FSH release. Conversely, Kisspeptin-10 operates upstream of GnRH neurons in the hypothalamus, serving as a primary gatekeeper of pulsatile gonadotropin secretion.

Additionally, long-acting GnRH analogs such as Triptorelin are utilized in laboratory studies to observe the desensitization and downregulation of pituitary gonadotropes following initial receptor hyper-stimulation. Understanding these mechanistic distinctions allows investigators browsing the PX1 Research laboratory catalog to select the exact target node required for their experimental design.

Current Literature: In Vitro and Animal Model Findings

Preclinical studies evaluating HCG in isolated Leydig cell culture models demonstrate dose-dependent increases in testosterone synthesis, driven by direct StAR transcription and enzymatic activation. In vitro assays using primary ovarian granulosa cells show that HCG exposure induces luteinization, upregulates progesterone secretion, and promotes vascular endothelial growth factor (VEGF) expression, providing a model for studying neo-vascularization in reproductive tissues.

In vivo animal models, including rodent and non-human primate studies, have investigated the protective effects of HCG on germ cell apoptosis during induced toxicological insult or cryopreservation protocols. Furthermore, research literature indicates that HCG receptor engagement may influence non-gonadal tissues expressing LHCGR, such as uterine endothelial cells, neural progenitor cells, and immune subpopulations, broadening its scope in experimental cell biology.

Analytical Verification: HPLC, Mass Spectrometry, and Endotoxin Testing

Ensuring experimental reproducibility requires research peptides HCG that meet stringent chemical purity standards. Low-quality or degraded peptide preparations introduce confounding variables, such as uncoupled subunits, truncated fragments, or bacterial endotoxins that invalidate cell viability assays. PX1 Research subjects every batch of HCG to a comprehensive testing matrix in an ISO 17025 accredited analytical facility.

Purity is quantitatively verified using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC), ensuring a peptide purity threshold exceeding 98%. Molecular identity and subunit composition are confirmed via Electrospray Ionization Mass Spectrometry (ESI-MS). Crucially, because endotoxins induce inflammatory cytokine responses in primary cell cultures, PX1 Research conducts Limulus Amebocyte Lysate (LAL) testing to verify endotoxin levels remain strictly below < 0.01 EU/mg.

Laboratory Reconstitution and Solution Preparation Protocols

Lyophilized research peptides HCG require precise handling to preserve tertiary structure and prevent denaturation. Reconstitution should be conducted within a certified laminar flow hood using sterile laboratory technique. Investigators typically rehydrate the lyophilized cake using sterile bacteriostatic water containing 0.9% benzyl alcohol to prevent microbial growth during multi-use experimental sampling.

To avoid shear-induced protein aggregation, the diluent should be allowed to run slowly down the interior glass wall of the vial rather than being forced directly onto the peptide powder. Swirl the vial gently until full dissolution is observed; mechanical vortexing or vigorous shaking must be avoided to prevent subunit dissociation or physical precipitation.

Thermal Stability, Storage Conditions, and Degradation Mitigation

In its lyophilized state, HCG exhibits high thermal stability when stored in a desiccated environment at -20°C to -80°C, protected from light exposure. Under these optimal cold-storage conditions, the un-reconstituted compound retains structural integrity for extended periods, minimizing spontaneous hydrolysis or oxidation of sensitive methionine and cysteine residues.

Once reconstituted into aqueous solution, the peptide exhibits increased susceptibility to thermal degradation and enzymatic cleavage. Reconstituted stock solutions should be stored at 2°C to 8°C for short-term experimental series (up to 30 days) or divided into single-use laboratory aliquots and stored at -80°C to prevent freeze-thaw cycles. Repeated freezing and thawing causes ice crystal formation that physically disrupts glycoprotein folding.

Sourcing USA-Manufactured Research Compounds with Proven Chain of Custody

Laboratory directors and academic procurement specialists must evaluate peptide vendors based on verifiable analytical data rather than generic marketing claims. PX1 Research manufactures all research compounds within state-of-the-art, GMP-compliant facilities located in the United States. Every lot is accompanied by a publicly accessible, lot-specific Certificate of Analysis (COA) detailing raw HPLC chromatograms and mass spectra.

To accommodate time-sensitive experimental timelines, PX1 Research operates dual fulfillment hubs in California and Arizona, providing same-day dispatch for orders placed before standard daily cutoffs. Laboratories seeking bulk procurement or custom research accounts can access specialized terms through our wholesale research portal.

Frequently Asked Questions

What is the purity level of PX1 Research peptides HCG?

PX1 Research supplies HCG with a confirmed purity of ≥98%, verified by RP-HPLC and mass spectrometry per individual batch.

How should lyophilized HCG be stored upon arrival in the laboratory?

Un-reconstituted lyophilized HCG should be stored at -20°C or -80°C in a dry, dark environment to maintain long-term peptide stability.

What solvent is recommended for reconstituting HCG for in vitro research?

Sterile bacteriostatic water (0.9% benzyl alcohol) or sterile phosphate-buffered saline (PBS) is standard, depending on the requirements of your specific assay.

Are PX1 Research peptides HCG tested for bacterial endotoxins?

Yes, every lot undergoes LAL endotoxin testing to ensure levels remain below < 0.01 EU/mg, protecting sensitive cell culture models.

Is HCG suitable for human consumption or clinical administration?

No. PX1 Research products are strictly for in vitro, animal, and preclinical laboratory research use only. They are not for human or veterinary medical use.

How does HCG differ mechanistically from Gonadorelin in research models?

HCG directly activates peripheral LHCGR receptors, whereas Gonadorelin acts on pituitary receptors to trigger endogenous LH and FSH release.

Where are PX1 Research compounds synthesized and shipped from?

All compounds are synthesized in USA-based, GMP-compliant facilities and shipped directly from fulfillment centers in California and Arizona.

How can researchers access lot-specific Certificates of Analysis?

Lot-specific COAs displaying raw HPLC and MS data are accessible directly on our website or by contacting PX1 Research support with your batch number.

Related pages

All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.